Pulmonary Neuroendocrine Cells and Small Cell Lung Carcinoma: Immunohistochemical Study Focusing on Mechanisms of Neuroendocrine Differentiation.
Ascl1
immunohistochemistry
molecular classification
pulmonary neuroendocrine cells
small cell lung carcinoma
Journal
Acta histochemica et cytochemica
ISSN: 0044-5991
Titre abrégé: Acta Histochem Cytochem
Pays: Japan
ID NLM: 0147110
Informations de publication
Date de publication:
29 Jun 2022
29 Jun 2022
Historique:
received:
28
03
2022
accepted:
12
04
2022
entrez:
13
7
2022
pubmed:
14
7
2022
medline:
14
7
2022
Statut:
ppublish
Résumé
Neuroendocrine (NE) differentiation has been histochemically detected in normal and cancer tissues and cells. Immunohistochemical analyses have provided a more detailed understanding of NE biology and pathology. Pulmonary NE cells are a rare lung epithelial type, and small cell carcinoma of the lung (SCLC) is a high-grade NE tumor. Pulmonary NE and SCLC cells share common mechanisms for NE differentiation. Neural or NE cell lineage-specific transcription factors, such as achaete-scute homologue 1 (Ascl1) and insulinoma-associated protein 1 (INSM1), are crucial for the development of pulmonary NE cells, and NE differentiation is influenced by the balance between Ascl1 and the suppressive neural transcription factor, hairy-enhancer of split 1, a representative target molecule of the Notch signaling pathway. In this review, we discuss the importance of Ascl1 and INSM1 in identifying pulmonary NE and SCLC cells and introduce Ascl1-related molecules detected by comparative RNA-sequence analyses. The molecular classification of SCLC based on the expression of lineage-specific transcription or co-transcription factors, including ASCL1, NEUROD1, POU2F3, and YAP1, was recently proposed. We attempted to characterize these 4 SCLC subtypes using integrated immunohistochemical studies, which will provide insights into the molecular characteristics of these subtypes and clarify the inter- and intratumor heterogeneities of SCLC.
Identifiants
pubmed: 35821751
doi: 10.1267/ahc.22-00031
pii: JST.JSTAGE/ahc/22-00031
pmc: PMC9253501
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
75-83Informations de copyright
2022 The Japan Society of Histochemistry and Cytochemistry.
Références
Cancer. 1965 May;18:592-602
pubmed: 14278892
Fed Proc. 1979 Aug;38(9):2288-94
pubmed: 37125
Adv Anat Embryol Cell Biol. 2021;233:C1
pubmed: 34302537
Transl Lung Cancer Res. 2018 Feb;7(1):32-49
pubmed: 29535911
Anat Rec. 1972 Mar;172(3):471-81
pubmed: 4110997
Cancer. 1968 Dec;22(6):1163-72
pubmed: 5705778
Cancer Res. 2000 Aug 1;60(15):4005-9
pubmed: 10945598
J Ultrastruct Res. 1965 Jun;12(5):668-86
pubmed: 5831056
Cancer Cell. 2021 Mar 8;39(3):346-360.e7
pubmed: 33482121
Histochem Cell Biol. 2020 Jun;153(6):443-456
pubmed: 32170367
PLoS Genet. 2016 Apr 19;12(4):e1005895
pubmed: 27093186
Cell Rep. 2016 Aug 2;16(5):1259-1272
pubmed: 27452466
Nature. 1997 Apr 24;386(6627):852-5
pubmed: 9126746
Cancer Res. 1985 Jun;45(6):2924-30
pubmed: 2985258
Science. 2016 Nov 4;354(6312):618-622
pubmed: 27811275
Cancer Cytopathol. 2019 Sep;127(9):598-605
pubmed: 31436913
J Thorac Oncol. 2017 Feb;12(2):334-346
pubmed: 27998793
Cancer Res. 2008 Mar 15;68(6):1647-55
pubmed: 18339843
Nat Rev Cancer. 2019 May;19(5):289-297
pubmed: 30926931
Mol Biol Cell. 2012 Aug;23(15):2856-66
pubmed: 22696682
Genes Dev. 2018 Jul 1;32(13-14):915-928
pubmed: 29945888
Diagnostics (Basel). 2020 Nov 13;10(11):
pubmed: 33202998
Development. 2000 Sep;127(18):3913-21
pubmed: 10952889
J Thorac Oncol. 2020 Dec;15(12):1823-1835
pubmed: 33011388
Nat Rev Cancer. 2017 Dec;17(12):725-737
pubmed: 29077690
Am J Pathol. 2015 Dec;185(12):3164-77
pubmed: 26482608
Frankf Z Pathol. 1949 Apr;60(3-4):517-59, illust
pubmed: 18151654
Endocr Pathol. 2003 Summer;14(2):133-9
pubmed: 12858003
J Thorac Oncol. 2022 Jan;17(1):141-153
pubmed: 34534680
Life Sci. 1969 Jun 1;8(11):577-85
pubmed: 4895061
Am J Respir Cell Mol Biol. 2012 Dec;47(6):768-75
pubmed: 22878413
Histochem Cell Biol. 1999 Apr;111(4):289-95
pubmed: 10219628
Science. 1973 Apr 27;180(4084):410-3
pubmed: 4121716
Prog Histochem Cytochem. 1999;34(4):247-322
pubmed: 10689732
Z Mikrosk Anat Forsch. 1954;61(1):73-81
pubmed: 14374964
Clin Cancer Res. 2015 May 15;21(10):2244-55
pubmed: 25979931
Lab Invest. 2019 Nov;99(11):1622-1635
pubmed: 31231131
Int J Cancer. 2016 Feb 15;138(4):927-38
pubmed: 26340530
Nature. 2015 Aug 6;524(7563):47-53
pubmed: 26168399
Cancer Res. 2009 Feb 1;69(3):845-54
pubmed: 19176379
Cancer Res. 1987 May 15;47(10):2594-8
pubmed: 2436751
J Morphol. 1990 Nov;206(2):217-23
pubmed: 2254941
Gan. 1968 Apr;59(2):123-9
pubmed: 5723057
Lung. 1987;165(5):297-304
pubmed: 3116354
J Histochem Cytochem. 1969 May;17(5):303-13
pubmed: 4143745
Proc R Soc Lond B Biol Sci. 1968 May 14;170(1018):71-80
pubmed: 4384885
J Thorac Oncol. 2016 Apr;11(4):453-74
pubmed: 26829312
Cancer Res. 2005 Dec 1;65(23):10680-5
pubmed: 16322211
Am J Respir Crit Care Med. 2005 Jul 1;172(1):136-9
pubmed: 15817800
Hum Cell. 2017 Jan;30(1):1-10
pubmed: 27785690
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14788-93
pubmed: 25267614
Cancer Res. 2001 Apr 1;61(7):3200-5
pubmed: 11306509
Mod Pathol. 2012 Jan;25 Suppl 1:S18-30
pubmed: 22214967
Lab Invest. 1967 Jul;17(1):88-98
pubmed: 6051009
Cancer Lett. 2004 Feb 20;204(2):159-69
pubmed: 15013215